美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

TrovaGene, Inc.

1.19

0.0000

成交量：- -

成交额：- -

市值：1,310.32万

市盈率：-0.42

高：1.19

开：1.19

低：1.19

收：1.19

52周最高：3.46

52周最低：0.7010

股本：1,101.11万

流通股本：963.56万

量比：- -

换手率：- -

股息：- -

股息率：- -

每股收益(TTM):-2.8000

每股收益(LYR):-2.7966

净资产收益率：-188.72%

总资产收益率：-76.48%

市净率：1.79

市盈率(LYR):-0.43

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

TrovaGene, Inc.

交易所：

NASDAQ

成立时间：

- -

员工人数：

- -

公司地址：

- -

官网：

http://trovageneoncology.com

邮编：

- -

电话：

- -

传真：

- -

简介：

Trovagene, Inc.是一家出于发展阶段的分子诊断公司，专注由专有产权的诊断技术的开发和市场推广，这种技术在各种医学诊所用于患者/疾病的扫描和监视。公司主要的内部焦点是操作新型的尿液分子诊断平台，以促进在治疗肿瘤领域的进步，外部焦点包括了在传染病、移植医疗和产前诊断领域发展合作。公司于2002年4月26日以Used Kar Parts公司之名成立于弗罗里达。

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券 | 轻松买卖美股港股A股/美债/ETF/Crypto/期权期货","description":"老虎证券提供多项优惠：港股&Crypto 0佣、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","keywords":"老虎证券,老虎证券开户,老虎证券香港,老虎证券登录,老虎证券官网,香港证券开户,证券公司开户,股票开户,香港证券公司,香港证券,证券公司,股票投资,投资app,投资平台,股票买卖,股票交易平台,股票app,证券app,新手投资","social":{"ogDescription":"老虎证券提供多项优惠：港股&Crypto 0佣、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/TROV/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"TROV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TROV\",,,,,undefined,":{"symbol":"TROV","market":"US","secType":"STK","nameCN":"TrovaGene, Inc.","latestPrice":1.19,"timestamp":1588881600000,"preClose":1.19,"halted":8,"volume":0,"delay":0,"changeRate":0,"floatShares":9635604,"shares":11011100,"eps":-2.8,"marketStatus":"休市中","change":0,"latestTime":"05-07 16:00:00 EDT","open":1.19,"high":1.19,"low":1.19,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.8,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1774252800000},"marketStatusCode":7,"symbolChange":{"newSymbol":"CRDF","executeDate":"2020-05-08"},"adr":0,"adrRate":0,"listingDate":1059624000000,"exchange":"NASDAQ","adjPreClose":1.19,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TROV\",,,,,undefined,":{"symbol":"TROV","floatShares":9635604,"roa":"-76.48%","roe":"-188.72%","lyrEps":-2.796607,"shares":11011100,"dividePrice":0,"high":1.19,"amplitude":0,"preClose":1.19,"low":1.19,"week52Low":0.701,"pbRate":"1.79","week52High":3.46,"institutionHeld":0,"latestPrice":1.19,"eps":-2.8,"divideRate":0,"volume":0,"delay":0,"ttmEps":-2.8,"open":1.19},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TROV\",params:#limit:5,,,undefined,":[{"market":"US","date":"2020-05-08","symbol":"TROV","oldSymbol":"TROV","newSymbol":"CRDF","exchange":"NASDAQ","type":"symbolChange","dateTimestamp":1588910400000},{"market":"US","date":"2020-05-05","symbol":"TROV","fiscalQuarterEnding":"2020/03","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1588651200000,"reportTimeType":"","actualEps":-1.02},{"market":"US","date":"2020-02-27","symbol":"TROV","fiscalQuarterEnding":"2019/12","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1582779600000,"reportTimeType":"","actualEps":-0.51},{"market":"US","date":"2019-11-07","symbol":"TROV","fiscalQuarterEnding":"2019/09","expectedEps":-0.84,"name":null,"time":"","type":"earning","dateTimestamp":1573102800000,"reportTimeType":"","actualEps":-0.71},{"market":"US","date":"2019-08-08","symbol":"TROV","fiscalQuarterEnding":"2019/06","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1565236800000,"reportTimeType":"","actualEps":-0.79}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TROV\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TROV\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://trovageneoncology.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0207},{"period":"1month","weight":-0.055},{"period":"3month","weight":-0.047},{"period":"6month","weight":-0.0228},{"period":"1year","weight":0.1469},{"period":"ytd","weight":-0.0489}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Trovagene, Inc.是一家出于发展阶段的分子诊断公司，专注由专有产权的诊断技术的开发和市场推广，这种技术在各种医学诊所用于患者/疾病的扫描和监视。公司主要的内部焦点是操作新型的尿液分子诊断平台，以促进在治疗肿瘤领域的进步，外部焦点包括了在传染病、移植医疗和产前诊断领域发展合作。公司于2002年4月26日以Used Kar Parts公司之名成立于弗罗里达。","exchange":"NASDAQ","name":"TrovaGene, Inc.","nameEN":"TrovaGene, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"TROV\",market:\"US\",,,undefined,":null}}